Real world study of regimen containing bevacizumab as first-line therapy in Chinese patients with advanced non-small cell lung cancer.
about
Real world study of regimen containing bevacizumab as first-line therapy in Chinese patients with advanced non-small cell lung cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Real world study of regimen co ...... ed non-small cell lung cancer.
@en
Real world study of regimen co ...... ed non-small cell lung cancer.
@nl
type
label
Real world study of regimen co ...... ed non-small cell lung cancer.
@en
Real world study of regimen co ...... ed non-small cell lung cancer.
@nl
prefLabel
Real world study of regimen co ...... ed non-small cell lung cancer.
@en
Real world study of regimen co ...... ed non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Real world study of regimen co ...... ced non-small cell lung cancer
@en
P2093
Hongyu Wang
Junling Li
Puyuan Xing
Xingsheng Hu
Xuezhi Hao
Zhijie Wang
P2860
P304
P356
10.1111/1759-7714.12650
P577
2018-05-16T00:00:00Z